US 8188076
Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
granted A61KA61K31/538A61P
Quick answer
US patent 8188076 (Compositions, synthesis, and methods of utilizing arylpiperazine derivatives) held by REVIVA PHARMACEUTICALS, INC. expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REVIVA PHARMACEUTICALS, INC.
- Grant date
- Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/538, A61P, A61P25/00, A61P25/18